Acute-on-Chronic Liver Failure (ACLF) in cirrhosis is a highly prevalent syndrome characterized by acute decompensation (AD), organ/system failure(s) and high 28-day mortality (32%) (1) . ACLF is classified in 3 grades of severity (ACLF-I, II and III) according to the number of organ failures and may follow four different clinical courses during hospitalization: resolution, improvement (reduction in ACLF-grade), steady course, or worsening (2) .
The Systemic Inflammation (SI) Hypothesis (3) proposes that ACLF is due to aggravation of the SI and associated systemic circulatory dysfunction (SCD) already present in AD, which leads to organ failure(s) as a consequence of organ hypoperfusion and direct deleterious effects of inflammatory mediators on the organ microcirculation and cell physiology homeostasis. According with this hypothesis, AD would occurs in the setting of chronic SI due to translocation of pro-inflammatory molecules (Pathogen Associated Molecular Patterns, PAMPs) from the intestinal lumen to the systemic circulation and/or to the release or Damage Associated Molecular Patterns (DAMPs) from the diseased liver. ACLF would be the result of further increase of SI in the context of precipitating events [PE: mainly active alcoholism/Acute alcoholic hepatitis (AAH), bacterial infections, or other PE]. The SI Hypothesis was based on cytokine studies in small series of patients (4-7) and on the CANONIC study, in which a close relationship between blood leukocytes (WBC) and C-reactive protein (CRP) levels and the presence and severity of ACLF was observed (1).
In the current study we assessed the SI Hypothesis by two approaches. The first was aimed at examining the relationship between markers of SI, measured at enrolment and sequentially during hospitalization, and the presence, severity and clinical course of ACLF and associated mortality in 552 patients hospitalized for AD. The second approach was aimed at assessing whether, as proposed by the SI hypothesis, ACLF in cirrhosis is not only due to an accentuation of the SCD and organ hypo-perfusion related to SI, but also to direct deleterious effects of SI in organ function. This assessment was performed by assessing the strength of the association of SCD and SI with ACLF and mortality.
Experimental Procedures
Patient selection, blood sampling, data collection and diagnostic criteria of organ failure and ACLF.
Two-hundred-thirty-seven patients with ACLF, either present at enrolment (n=180) or developed during hospitalization (n=57), and 285 patients without ACLF derived from the CANONIC investigation (1) were studied. Selection criteria were: 1. Availability of blood samples at enrollment; 2. Prospective intensive surveillance during hospitalization. Follow-up plasma samples obtained at pre-specified visits during hospitalization (2, 3-7, 8- Clinical, laboratory and follow-up data were obtained from individual electronic-CRF.
There was no patient with HIV infection. Diagnosis of organ failure, ACLF and ACLF grades are based on the CLIF-Consortium Organ Failure score and the Canonic study criteria (1, 8 ) (see Supporting Information). Clinical diagnosis of AAH was based on the NIAAA Alcoholic Hepatitis Consortia criteria (9): active alcoholism, serum bilirubin>3 mg/dL, AST>50 IU/mL and AST/ALT ratio> 1.5. SIRS was diagnosed using WBC count, heart and respiratory rates and body temperature (10) .
Characterization of SI in AD. Relationship with ACLF.
To characterize SI, we measured the plasma levels of 29 cytokines involved in innate and adaptive immune responses and the redox state of circulating albumin (a marker of systemic oxidative stress (11, 12) ). Baseline measurements were obtained at enrolment or at ACLF onset in the 20 out of the 57 patients developing ACLF during hospitalization. To assess the role of SI in the pathogenesis of ACLF, we compared baseline plasma cytokine levels of patients with and without ACLF at enrolment and examined the relationship between these measurements and ACLF severity. Also we assessed the chronological relationship between changes in SI and the course of ACLF during hospitalization by comparing the levels of SI markers at ACLF diagnosis with those at the last measurement during hospitalization (prior to discharge or liver transplantation or death). Median time from enrolment to last assessment: 15 days; percentile 25-75:7-28) . Differences in baseline cytokine profiles according to the etiology (PE) were also assessed to identify potential differences in SI mechanisms.
Finally, pro-inflammatory/anti-inflammatory cytokine ratios were determined in healthy subjects and patients with and without ACLF to assess the profile of pro-and anti-inflammatory cytokine response in these patients. Cytokines were measured using a multiplexed bead-based immunoassay on a Luminex 100 Bioanalyzer (Supporting Information and Supplementary Table 1) .
Systemic oxidative stress was estimated by measuring the percentage of albumin oxidized at the Cysteine-34 residue (Cys34) over the total albumin concentration.
The free Cys34 accounts for about 80% of the antioxidant capacity of human plasma (12, 13) . In the presence of systemic oxidative stress, Cys34 is converted from the reduced form with Cys34 into the free sulphydryl form (human mercaptalbumin, HMA) to mixed disulfides (human nonmercaptalbumin 1, HNA1). This process is reversible (14) (15) (16) . A smaller fraction of Cys34, however, is highly oxidized to sulfenic, sulfinic and finally sulfonic forms (human nonmercaptalbumin 2, HNA2).
Oxidation of albumin to HNA2 is irreversible and causes intense modifications of the protein structure (15, 16) . HNA1+HNA2 as well as HNA2 were used as markers of systemic oxidative stress (17) (18) (19) . Reasons for the selection of the redox state of albumin over other markers of systemic oxidative stress and the methodology of measurement are detailed in Supporting Information.
Strength of the association of markers of SI and of SCD with ACLF or ACLF with renal failure (ACLF-RF).
Systemic circulatory function defines a series of physiological processes influencing the cardiac output and the activity of endogenous vasoactive systems that regulate arterial pressure and global organ perfusion. Micro-circulatory function (which is mainly dependent of endothelial and tissue factors) regulates the blood and oxygen delivery to the cells. Since plasma renin concentration (PRC) and the plasma concentration of copeptin (PCC) are very sensitive to changes in effective circulating blood volume (20, 21) , they were selected as markers of systemic circulatory dysfunction for this study. Copeptin is a stable cleavage product of the C-terminal part of the antidiuretic hormone (ADH) precursor that is produced in a 1:1 fashion with ADH. It is widely used to estimate vasopressin release because it allows an easier and more accurate immunological testing than ADH (21) . Other criteria used for the selection of PRC and PCC as markers of systemic circulatory dysfunction and the methodology of measurements are detailed in Supporting Information.
Copeptin (as ADH) is filtered by the glomeruli and therefore may overestimate ADH secretion in patients with ACLF-RF.
The strength of the association of ACLF with PRC and with IL-8, IL-6 or HNA2 was estimated to assess whether ACLF is related not only to SCD but also to other effects of SI in organ function. IL-8, IL-6 and HNA2 were selected because they were the inflammatory markers more strongly associated with ACLF in our patients (see Results). PRC was selected because it was not influenced, as copeptin, by GFR in our patients (see Results) The strength of the association of ACLF-RF with markers of SI and PRC were also compared as an outcome, since renal failure is a paradigmatic organ failure in cirrhosis thought to be caused by severe impairment in cardiovascular function and organ hypo-perfusion (3, 20, 22) . Four different approaches to analysis were used. Finally we assessed the association of changes in markers of SI and PRC during hospitalization with changes in the clinical course of patients with and without ACLF.
SI, SCD and mortality.
We also assessed the strength of the association of baseline levels of SI and SCD markers and of changes in these markers during hospitalization with short-term (28-day and 90-day) mortality.
Data analysis and statistical details
Among the 29 cytokines determined, 12 were undetectable in a high percentage (more than 30%) of the cirrhotic patients studied (Supplementary Table 2 ). Due to this feature, two independent analyses on the association of cytokines with ACLF and mortality were performed. The main analysis, which included the 17 cytokines showing detectable plasma levels in most patients, is detailed in the main body of the article. Undetectable levels of healthy subjects in this analysis (the majority of values for some cytokines) were assigned a value equal to the lower limit of detection. The second analysis was performed with the 12 cytokines with more than 30% of undetectable values. Results with this group are briefly mentioned in the text of the article and detailed in the Supporting Information.
Discrete variables are shown as counts (percentage) and continuous variables as mean (standard deviation). Non-normally distributed variables are summarized by the median (interquartile range) and were log-transformed for some statistical analyses and for graphical comparisons. In univariate statistical comparisons, the Chi-square test was used for categorical variables, while the Student's t-test or ANOVA were used for normal continuous variables and the Wilcoxon signed rank test or the Kruskall-Wallis test for continuous variables not normally distributed. In all statistical analyses, significance was set at p<0.05.
Results

Characterization of SI in patients with AD. Relationship with ACLF.
The patient characteristics were similar to those of the whole CANONIC cohort (1) (Supplementary Table 3 Table 4) .
As compared to healthy controls, patients with cirrhosis showed markedly increased levels of all cytokines ( Table 1) . Patients presenting ACLF exhibited significantly higher levels of pro-inflammatory cytokines than patients without ACLF. The antiinflammatory cytokines IL-10 and IL-1ra followed a similar pattern. In contrast, differences in the plasma levels of the remaining cytokines were slight or not significant. No significant differences in plasma cytokine levels at ACLF diagnosis were observed between patients with ACLF at enrolment and those who developed ACLF after enrolment (data not shown).
There was a clear direct relationship between the intensity of SI and severity of ACLF as indicated by a parallel and significant increase in IL-6, IL-8 and IL-1ra from ACLF grade I to ACLF grades II and III ( Table 2 ).
The IL-8/IL-10 and IL-6/IL-10 ratios were determined as markers of the proinflammatory/anti-inflammatory cytokine response (Supplementary Figure 1) . The two ratios were significantly higher in patients with cirrhosis than in healthy subjects.
No significant differences between patients with and without ACLF were observed.
Supplementary Tables 5 and 6 show the results obtained with the cytokines
showing detectable values in less than 70% of patients. All cytokines included in this analysis were also significantly higher in patients with decompensated cirrhosis with and without ACLF than in healthy controls (Supplementary Table 5 ). However, significant differences between patients with and without ACLF were observed only in the inflammatory cytokine MIP-1α (higher in patients with ACLF). There were no significant differences in any of the cytokines included in this analysis across the three grades of severity of ACLF (Supplementary Table 6 ).
The profile of the 17 cytokines included in the main analysis varied according to the PE in patients with ACLF ( Table 3) . ACLF precipitated by bacterial infection showed higher levels of TNFα, IL-6 and IL-1ra than ACLF precipitated by active alcoholism (p=0.004; p=0.02; and p=0.0269, respectively) or ACLF associated with other PEs or without PE (p=0.04; p=0.0002; and p=0.02, respectively). ACLF precipitated by active alcoholism showed higher levels of IL-8 than ACLF precipitated by bacterial infection (p=0.0001) or ACLF associated with other PEs or without PE (p=0.001). The cytokine profile in ACLF precipitated by both bacterial infections and active alcoholism shared the characteristics of ACLF precipitated by infection and active alcoholism alone. In ACLF patients with other PEs or without PE no cytokine showed significantly increased levels in comparison to the other groups of patients with ACLF.
Supplementary Table 7
shows that the profile associated with active alcoholism was due to a great extent to the extremely high values of IL-8 observed in patients with AAH. However, the plasma levels of IL-8 were also higher in patients with active alcoholism without AAH than in those without active alcoholism (Supplementary Table 7 ). This increase in the plasma levels of IL-8 observed in patients with alcoholic cirrhosis, active alcoholism but no AAH was not detected in alcoholic cirrhotic patients who stopped drinking (Supplementary Table 7 ).
Supplementary Table 8 shows the cytokine profile in patients with and without SIRS. Patients with SIRS showed significantly higher plasma levels of the proinflammatory cytokines IL-6, IL-8, MCP-1, MIP-1β and G-CSF and of the antiinflammatory cytokines IL-10 and IL-1ra than patients without SIRS.
HNA1+HNA2 and HNA2 were markedly increased (p<0.001) in cirrhotic patients with and without ACLF as compared to healthy controls ( Table 1) . Values for both HNA1+HNA2 and HNA2 were significantly higher in patients with ACLF than in those without ( Table 1) . There were no significant changes in the redox state of albumin across the three ACLF grades ( Table 2) .
SCD in patients with and without ACLF.
As shown in Table 1 , PRC and PCC were markedly above normal range in patients with and without ACLF but values of these markers were significantly higher in the former than in the latter group. PCC was significantly higher in patients with ACLF-RF IL-8, IL-6 and HNA2, the SI markers more closely associated with the presence and severity of ACLF at enrolment (Tables 1 and 2) , and PRC were analyzed for this purpose. PCC was not included in this analysis due to its low ability for the assessment of SCD in patients with ACLF-RF. (Supplementary Figure 4) . The stepwise linear regression model fitted for CLIF-C Organ Failure Score based on the significance of the increase in model R-Square allowed to select HNA2 (p<0.0001) and both cytokines (IL-8, p<0.0001; IL-6, p=0.0008) as the markers most strongly related to the severity of ACLF. Similarly the stepwise model fitted for serum creatinine allowed to select HNA2 (p<0.0001) and IL-6 (p=0.0114) as the markers more strongly related to the severity of renal failure. In both models, PRC did not contribute significantly to improve the final R-Square.
There was a significant association between changes in markers of SI during hospitalization and the course of ACLF (Table 4) . Improvement of ACLF was associated with decrease whereas worsening of ACLF was associated with increase in IL-6, IL-8 and HNA2. Inflammatory markers did not change in the steady form of ACLF or in patients with no ACLF throughout the study. In contrast, no relationship was observed between changes in PRC and the clinical course of ACLF
SI and mortality.
The strength of association between SI, SCD and short-term mortality were also assessed considering IL-8, IL-6, HNA2 and PRC values. Baseline values of IL-8, IL-6
(not shown) and HNA2 but not of PRC were strongly associated with 28-day mortality (Figure 3 ) and 90-day mortality (Supplementary Figure 6) . Similarly, there was a significant association between the course of SI during hospitalization and the 28-day and 90-day mortality ( Table 5) . One hundred and three patients had CRP data available at enrolment and at the last follow-up assessment. Changes in CRP from enrolment in those patients who survived at 28 (median -4.0, IQR -13.1-1.6) and 90 days (-2.4, -11.1-1.9) were not significantly different from those corresponding to patients who died (-1.3, -19.6-3.7 and -7.1, -20.7-0; p-values 0.4918 and 0.2044, respectively). Twenty-eight-day and 90-day mortality rates were also significantly associated (p<0.0001) with SIRS at enrolment (23 out of 78 patients with SIRS, 29.5%, and 47 out of 433 without SIRS, 10.6%, died within 28-day after enrolment; at 90 days; the mortality rates were 42.9% and 21.6%, respectively).
Eighteen patients showed extremely high levels of IL-8 (>800 UI/ml) and/or IL-6 (>1000 UI/ml) at enrolment (Figure 2) . The prevalence of severe forms of ACLF (grades 2 or 3) and the 28-day mortality rate in this group of patients (39% and 28%%, respectively) was higher (p= 0.0833 and p=0.0774) than in the rest of the patients (21% and 13%, respectively).
Discussion
The discussion of the article is divided in four parts: 1. Role of SI in the pathogenesis and clinical course of AD and ACLF; 2. Cytokine response; 3. Mechanisms of organ failure in ACLF; 4. Relationship between SI and mortality.
The first part of the analysis (Tables 1-3 ) strongly suggests that SI is a major mechanism of AD and ACLF and supports most of the proposals of the SI Hypothesis: 1. AD of cirrhosis occurs in the setting of severe SI and oxidative stress; 2. SI is significantly more severe in patients with ACLF than in patients without ACLF.
Interestingly, the reported levels of IL-6, IL-8 and TNFα in patients with severe sepsis, a condition also associated with organ failure, are similar to those found in our patients with ACLF (23-25); 3. Severity of SI correlates closely with severity of ACLF; 4. Finally, the course of SI during hospitalization is strongly associated with the course of AD and ACLF (development of ACLF during hospitalization in patients without ACLF at enrolment or improvement, steady course or worsening of ACLF in patients with ACLF at enrolment).
The characterization of cytokine response in our patients (second part of the analysis; Tables 1-3, Supplementary Table 7 and Supplementary Figure 1 ) disclosed interesting features. Whereas all the 17 cytokines and chemokines included in the main analysis were significantly increased in patients with AD with respect to healthy controls, only those involved in innate immune response were clearly 'upregulated' in patients with ACLF with respect to patients without ACLF. Indeed, we found that patients with ACLF had a predominance of pro-inflammatory cytokines (i.e., TNFα and IL-6) and chemokines (IL-8, MCP-1, IP-10 and MIP-1β). These patients also had increased levels of G-CSF and GM-CSF, key regulatory cytokines that target committed progenitors to promote differentiation and activation of monocytes and neutrophils (26) . In contrast, among other cytokines that are involved in the activation and shaping of the adaptive immune system (IFNγ, IL-17a and IL-7), IFNγ was only slightly higher in patients with ACLF than in those without. These findings suggest that whereas activation of both the innate and adaptive immune systems participates in the SI associated with AD, a dysregulated innate immune response might be the predominant mechanism in the progression of AD to ACLF.
The assessment of the overall cytokine profile showed that not only pro-inflammatory molecules but also major anti-inflammatory cytokines such as IL-10 and IL-1ra were increased in patients with AD with and without ACLF indicating a generalized activation of the inflammatory cytokines. There was, however, a clear unbalance in favor of pro-inflammatory cytokines as indicated by the significantly higher IL-6/IL-10 and IL-8/IL-10 ratios observed in patients with and without ACLF as compared to healthy subjects.
Another outstanding feature was the observation of clear differences in cytokine profile of patients with ACLF according to the type of PE. Patients with active alcoholism as PE exhibited very high IL-8 levels, as described previously (27, 28) .
Such increase in IL-8 was observed both in patients with and without AAH, although the grade of increase was greater in the former group than in the second. Patients with bacterial infection had a characteristic increase of a set of inflammatory cytokines. Finally, patients with other or without PE had no differential increase in any cytokine with respect to patients with active alcoholism or bacterial infection as PE.
These data suggest specific mechanisms for SI depending on the underlying trigger of ACLF. They also suggest that ACLF in patients with unidentifiable PE is unlikely related to unrecognized bacterial infection. Finally, they support a cause-to-effect relationship between PE, SI and ACLF development. This suggestion, however, does not exclude other mechanisms. In fact, dysfunctional or damaged organs by itself may stimulate cytokine and reactive oxygen species production (29) and, therefore, contribute to the development and/or progression of ACLF.
It is important to note that increased plasma levels of G-CSF, GM-CSF, TNFα, IL-6
and IFNγ have been shown to participate in the process called 'emergency hematopoiesis' which develops in the context of SI (30, 31) . Therefore, the activation of these cytokines found in patients with ACLF probably contributes to the leukocytosis associated with this syndrome and explain the close relationship between WBC, ACLF severity and patient prognosis (1,3) .
The mechanism by which SI induces ACLF was explored in the third part of the analysis (Figures 1 and 2, Supplementary Figures 2, 3 Patients who died are predominantly in the right part of the panels (higher degree of SI). Lower Panels (C and D) show the mortality rates observed within each tertile of both PRC and IL-8 and PRC and HNA2. Differences in mortality rates within tertiles (T2 vs T1 and T3 vs T2) were statistically significant only with IL-8 and HNA2. 
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